• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔鳞状细胞癌分级系统——最佳生存预测因子分析。

Oral squamous cell carcinoma grading systems--analysis of the best survival predictor.

机构信息

Pathology Graduate Program, Fluminense Federal University, Niterói, Brazil.

出版信息

J Oral Pathol Med. 2012 Jan;41(1):34-9. doi: 10.1111/j.1600-0714.2011.01068.x. Epub 2011 Sep 8.

DOI:10.1111/j.1600-0714.2011.01068.x
PMID:21902722
Abstract

BACKGROUND

The TNM system has been used for decades in an attempt to predict clinical behavior and appropriate therapy for oral squamous cell carcinomas. Histopathologic classifications can be useful as an additional predictive tool. The purpose of this study was to apply four grading systems (Multiparameter Grading System, Malignancy Grading of the Deep Invasive Margins, World Health Organization grading system, and Histologic Risk Assessment) to oral squamous cell carncinomas and evaluate each system based on clinicopathologic parameters and patient survival.

METHODS

The files of 53 patients diagnosed with primary oral squamous cell carcinoma at the Brazilian National Cancer Institute were evaluated. All hematoxylin and eosin-stained slides were reviewed to confirm the original diagnosis and to determine histopathologic grading. Clinicopathologic information was obtained from medical records and tumor registries. Statistical analysis was performed using Fisher's exact test or the chi-square test, the Kaplan-Meier method, and the log-rank test.

RESULTS

The Multiparameter Grading System was statistically associated with pathologic staging (P = 0.02) and lymph node involvement (P = 0.0009). Differences in overall 5-year survival were significant for Histologic Risk Assessment (P = 0.015), pathologic staging (P = 0.001), lymph node status (P < 0.0001), and recurrence (P = 0.0001). Differences in cancer-specific 5-year survival were significant for Histologic Risk Assessment (P = 0.029), pathologic staging (P = 0.002), lymph node involvement (P < 0.0001), and recurrence (P < 0.0001). Poorly differentiated tumors were associated with the worst disease-free survival (P = 0.031) and recurrence (P = 0.043).

CONCLUSION

Of the grading systems evaluated, Histologic Risk Assessment demonstrated the best results for survival prediction in oral squamous cell carcinoma.

摘要

背景

TNM 系统已使用数十年,试图预测口腔鳞状细胞癌的临床行为和适当的治疗方法。组织病理学分类可用作附加的预测工具。本研究的目的是将四种分级系统(多参数分级系统、深部浸润边缘恶性分级、世界卫生组织分级系统和组织学风险评估)应用于口腔鳞状细胞癌,并根据临床病理参数和患者生存情况评估每种系统。

方法

评估了在巴西国家癌症研究所诊断为原发性口腔鳞状细胞癌的 53 名患者的档案。所有苏木精和伊红染色切片均进行了复查,以确认原始诊断并确定组织病理学分级。临床病理信息从病历和肿瘤登记处获得。Fisher 确切检验或卡方检验、Kaplan-Meier 方法和对数秩检验用于统计分析。

结果

多参数分级系统与病理分期(P=0.02)和淋巴结受累(P=0.0009)具有统计学相关性。组织学风险评估(P=0.015)、病理分期(P=0.001)、淋巴结状态(P<0.0001)和复发(P=0.0001)的总 5 年生存率差异有统计学意义。组织学风险评估(P=0.029)、病理分期(P=0.002)、淋巴结受累(P<0.0001)和复发(P<0.0001)的癌症特异性 5 年生存率差异有统计学意义。低分化肿瘤与无病生存率最差(P=0.031)和复发(P=0.043)相关。

结论

在所评估的分级系统中,组织学风险评估在预测口腔鳞状细胞癌的生存方面显示出最佳结果。

相似文献

1
Oral squamous cell carcinoma grading systems--analysis of the best survival predictor.口腔鳞状细胞癌分级系统——最佳生存预测因子分析。
J Oral Pathol Med. 2012 Jan;41(1):34-9. doi: 10.1111/j.1600-0714.2011.01068.x. Epub 2011 Sep 8.
2
Clinical and histopathologic independent prognostic factors in oral squamous cell carcinoma: a retrospective study of 334 cases.口腔鳞状细胞癌的临床和组织病理学独立预后因素:334例回顾性研究
J Oral Maxillofac Surg. 2008 Aug;66(8):1570-9. doi: 10.1016/j.joms.2007.12.024.
3
Contralateral lymph neck node metastasis of squamous cell carcinoma of the oral cavity: a retrospective analytic study in 315 patients.口腔鳞状细胞癌对侧颈部淋巴结转移:一项对315例患者的回顾性分析研究
J Oral Maxillofac Surg. 2008 Jul;66(7):1390-8. doi: 10.1016/j.joms.2008.01.012.
4
[Clinicopathologic features and prognostic factors of cervical lymph node metastasis in oral squamous cell carcinoma].[口腔鳞状细胞癌颈淋巴结转移的临床病理特征及预后因素]
Ai Zheng. 2005 Feb;24(2):208-12.
5
Risk factors for distant metastasis in squamous cell carcinoma of the oral cavity.口腔鳞状细胞癌远处转移的危险因素。
J Oral Maxillofac Surg. 2013 Jul;71(7):1291-7. doi: 10.1016/j.joms.2012.12.023. Epub 2013 Feb 21.
6
Prospective evaluation of outcome after transoral CO(2) laser resection of T1/T2 oral squamous cell carcinoma.经口二氧化碳激光切除T1/T2期口腔鳞状细胞癌术后结局的前瞻性评估
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Aug;112(2):180-7. doi: 10.1016/j.tripleo.2010.09.078. Epub 2011 Jan 12.
7
Predictors for tumor recurrence after primary definitive surgery for oral cancer.口腔癌初次根治性手术后肿瘤复发的预测因素。
J Oral Maxillofac Surg. 2012 Jul;70(7):1724-32. doi: 10.1016/j.joms.2011.06.228. Epub 2011 Sep 21.
8
Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients.原发性口腔鳞状细胞癌患者颈部淋巴结中E-钙黏蛋白的表达
Arch Oral Biol. 2007 Aug;52(8):740-7. doi: 10.1016/j.archoralbio.2007.01.013. Epub 2007 Feb 28.
9
The number of pathologically positive lymph nodes and pathological tumor depth predicts prognosis in patients with poorly differentiated squamous cell carcinoma of the oral cavity.病理性阳性淋巴结数量和肿瘤病理深度可预测口腔低分化鳞状细胞癌患者的预后。
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e223-30. doi: 10.1016/j.ijrobp.2011.03.060. Epub 2011 Jun 2.
10
[Mouth floor and mobile tongue epidermoid carcinomas thickness: prognostic value].[口腔底部和活动舌部表皮样癌的厚度:预后价值]
Rev Stomatol Chir Maxillofac. 2008 Apr;109(2):81-5. doi: 10.1016/j.stomax.2007.12.003. Epub 2008 Mar 6.

引用本文的文献

1
Clinicopathologic Predictors of Survival Following Oral Cancer Surgery: A Retrospective Cohort Study.口腔癌手术后生存的临床病理预测因素:一项回顾性队列研究。
Cancers (Basel). 2025 Jul 24;17(15):2454. doi: 10.3390/cancers17152454.
2
Comparison of Clinical Parameters, Histopathological Features and Status of Intraoperative Surgical Margins Between Recurrent and Non-Recurrent Oral Squamous Cell Carcinoma.复发性与非复发性口腔鳞状细胞癌的临床参数、组织病理学特征及术中手术切缘状态的比较
Indian J Otolaryngol Head Neck Surg. 2025 Mar;77(3):1565-1572. doi: 10.1007/s12070-025-05380-0. Epub 2025 Feb 8.
3
Automated classification of pathological differentiation in head and neck squamous cell carcinoma using combined radiomics models from CET1WI and T2WI.
使用来自CET1WI和T2WI的联合影像组学模型对头颈部鳞状细胞癌的病理分化进行自动分类。
Clin Oral Investig. 2024 Dec 21;29(1):25. doi: 10.1007/s00784-024-06110-6.
4
The epidemiological and histopathological factors for delayed local recurrence in oral squamous cell carcinoma.口腔鳞状细胞癌局部延迟复发的流行病学和组织病理学因素。
Maxillofac Plast Reconstr Surg. 2024 Nov 12;46(1):38. doi: 10.1186/s40902-024-00443-8.
5
Comparison of different histomorphological grading systems in vulvar squamous cell carcinoma.外阴鳞状细胞癌不同组织形态学分级系统的比较
Arch Gynecol Obstet. 2024 Dec;310(6):3091-3097. doi: 10.1007/s00404-024-07809-3. Epub 2024 Nov 9.
6
Overexpression of a disintegrin and metalloproteinase 9 (ADAM9) in relation to poor prognosis of patients with oral squamous cell carcinoma.去整合素和金属蛋白酶9(ADAM9)的过表达与口腔鳞状细胞癌患者的不良预后相关。
Discov Oncol. 2024 Oct 23;15(1):582. doi: 10.1007/s12672-024-01422-1.
7
Protocol for correlation of histological risk assessment/scoring system with a depth of invasion in oral squamous cell carcinoma.口腔鳞状细胞癌中组织学风险评估/评分系统与浸润深度的相关性研究方案。
F1000Res. 2024 May 31;12:1326. doi: 10.12688/f1000research.134757.2. eCollection 2023.
8
Recurrence of oral squamous cell carcinoma in surgically treated patients at Khartoum Teaching Dental Hospital retrospective cross-sectional study.喀土穆教学牙科医院手术治疗的口腔鳞状细胞癌患者的复发:回顾性横断面研究。
BMC Cancer. 2024 Jun 28;24(1):781. doi: 10.1186/s12885-024-12562-6.
9
Improved recurrence rates and progression-free survival in primarily surgically treated oral squamous cell carcinoma - results from a German tertiary medical center.主要经手术治疗的口腔鳞状细胞癌的复发率和无进展生存率提高 - 来自德国三级医疗中心的结果。
Clin Oral Investig. 2024 Apr 20;28(5):262. doi: 10.1007/s00784-024-05644-z.
10
Temporal and spatial patterns of recurrence in oral squamous cell carcinoma, a single-center retrospective cohort study in China.中国单中心回顾性队列研究:口腔鳞状细胞癌的复发时空模式。
BMC Oral Health. 2023 Sep 19;23(1):679. doi: 10.1186/s12903-023-03204-7.